Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evicel fibrin sealant in bilateral total knee arthroplasty
2009-018245-21Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of porcine fibrin sealant in knee osteoarthritis (OA), sponsored by Rigshospitalet. Primary endpoint: Postoperative blood loss by drain at 24 hours. Started Jan 2010; status: completed.
02
Drugs
porcine fibrin sealant
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2009-018245-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018245-21.